Krux
March 20, 2026
Verily Raises $300M As Alphabet Loosens Its Grip
Published: March 20, 2026 at 12:57 AM
Updated: March 20, 2026 at 12:57 AM
100-word summary
Alphabet's health spinoff Verily just raised $300 million from Series X Capital, with Alphabet stepping back to minority investor. The shift hands Verily more independence to scale its AI health platform without parent company control. The timing reveals a bet: that hospitals will pay for software that turns messy patient data into treatment recommendations. Verily's bundling the round with partnerships including Samsung (for wearable biomarkers) and Salesforce (integrating health records with AI agents). It even rebranded from LLC to corporation. Translation: Verily wants to look less like an Alphabet science project and more like a real business investors can exit.
What happened
Alphabet's health spinoff Verily just raised $300 million from Series X Capital, with Alphabet stepping back to minority investor. The shift hands Verily more independence to scale its AI health platform without parent company control. The timing reveals a bet: that hospitals will pay for software that turns messy patient data into treatment recommendations. Verily's bundling the round with partnerships including Samsung (for wearable biomarkers) and Salesforce (integrating health records with AI agents). It even rebranded from LLC to corporation.
Why it matters
Translation: Verily wants to look less like an Alphabet science project and more like a real business investors can exit.